In HIV, elvitegravir fixed combination has lesser benefit for treatment-naive patients

The drug combination of elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil has been approved in Germany since May 2013 for the treatment of adults infected with human immunodeficiency virus type 1 .

http://www.medicalnewstoday.com/releases/266430.php